U.S. Senators Jon Tester (D-Mont.) and Mike Braun (R-Ind.) today introduced their bipartisan Industrial Hemp Act to ease the burden on farmers who grow grain and fiber hemp, or “industrial hemp.” The Senators’ bill would exempt farmers exclusively growing industrial hemp from the burdensome background checks and costly sampling and testing protocols required for farmers growing cannabinoid hemp.
“Montana farmers don’t need government bureaucrats putting unnecessary burdens on their operations,” said Senator Tester.
“It’s time we cut red tape, and make it easier for industrial hemp farmers to get their product to market. My bipartisan bill builds on Montana’s leadership on hemp policy and creates good-paying jobs for folks across rural America.”
“It’s important that we set American farmers up for success by cutting burdensome regulations and red tape,” said Senator Braun. “This legislation will expand opportunities for industrial hemp producers in Indiana and across the country and allow them to tap into one of the fastest growing agricultural markets.”
“The Midwest Hemp Council applauds Senator Braun’s and Senator Tester’s unwavering commitment to helping American farmers rebuild a domestic supply chain of hemp grain and fiber crops. The Industrial Hemp Act of 2023 will reduce unnecessary regulatory barriers for our farmers and provide them with the certainty needed to continue to invest their time and treasure into meeting the growing demand for hemp grain and fiber crops across the country. It’s time to unleash the ingenuity of the American farmer,” said Justin Swanson, President of the Midwest Hemp Council.
U.S. Senators Jon Tester (D-Mont.) and Mike Braun (R-Ind.) today introduced their bipartisan Industrial Hemp Act to ease the burden on farmers who grow grain and fiber hemp, or “industrial hemp.” The Senators’ bill would exempt farmers exclusively growing industrial hemp from the burdensome background checks and costly sampling and testing protocols required for farmers growing cannabinoid hemp.
“Montana farmers don’t need government bureaucrats putting unnecessary burdens on their operations,” said Senator Tester. “It’s time we cut red tape, and make it easier for industrial hemp farmers to get their product to market. My bipartisan bill builds on Montana’s leadership on hemp policy and creates good-paying jobs for folks across rural America.”
“It’s important that we set American farmers up for success by cutting burdensome regulations and red tape,” said Senator Braun. “This legislation will expand opportunities for industrial hemp producers in Indiana and across the country and allow them to tap into one of the fastest growing agricultural markets.”
“The Midwest Hemp Council applauds Senator Braun’s and Senator Tester’s unwavering commitment to helping American farmers rebuild a domestic supply chain of hemp grain and fiber crops. The Industrial Hemp Act of 2023 will reduce unnecessary regulatory barriers for our farmers and provide them with the certainty needed to continue to invest their time and treasure into meeting the growing demand for hemp grain and fiber crops across the country. It’s time to unleash the ingenuity of the American farmer,” said Justin Swanson, President of the Midwest Hemp Council.
About Acannability
Acannability is a cooperative source of communication, education, and standards for the cannabis and hemp industries.™
© 2022 Acannability, LLC
Links
Background info
Luteolin (LTL) is a naturally occurring flavonoid that is found not only in cannabis but also in various other plants, including fruits, vegetables, and herbs. It is a polyphenolic compound known for its potential health benefits and antioxidant properties. In cannabis, luteolin is one of several flavonoids present in the plant, and it contributes to the complex chemical profile of the cannabis plant. Luteolin is believed to have anti-inflammatory, antioxidant, and neuroprotective properties, making it an area of interest in medical and therapeutic research. Some studies suggest that luteolin may play a role in modulating the endocannabinoid system and could potentially influence the effects of other compounds found in cannabis, such as cannabinoids. However, further research is needed to fully understand the specific actions and potential therapeutic applications of luteolin in the context of cannabis.
LTL as an antioxidant
The article titled “Anti-Oxidant, Anti-Inflammatory and Anti-Allergic Activities of Luteolin” by Seelinger, Merfort, and Schempp, highlights the antioxidant properties of luteolin. The study underscores luteolin’s role as a potent antioxidant, emphasizing its ability to neutralize harmful free radicals and reduce oxidative stress. Luteolin’s antioxidant activity is crucial in protecting cells and tissues from damage caused by reactive oxygen species, which are implicated in various chronic diseases and aging processes. Additionally, the article discusses luteolin’s anti-inflammatory and anti-allergic activities, suggesting that its antioxidant properties may play a significant role in these effects as well. By scavenging free radicals and mitigating oxidative stress, luteolin has the potential to contribute to overall health and may be a promising natural compound for preventing and managing conditions associated with inflammation and allergies. This research underscores the multifaceted benefits of luteolin, particularly in the context of its antioxidant properties, which have important implications for health and disease prevention.
LTL as neuroprotective
The article titled “Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2–ARE pathway” by Jianguo Xu et al., published in Free Radical Biology and Medicine in 2014, offers insights into the neuroprotective properties of Luteolin. The study investigates how Luteolin exerts its neuroprotective effects in models of traumatic brain injury (TBI) through the Nrf2–ARE pathway. The findings suggest that Luteolin activates the Nrf2-ARE (nuclear factor erythroid 2-related factor 2-antioxidant response element) pathway, which is a key cellular defense mechanism against oxidative stress and inflammation. This activation leads to the upregulation of antioxidant enzymes and other cytoprotective factors, helping to mitigate the detrimental effects of TBI on brain tissue. Consequently, Luteolin emerges as a potential therapeutic agent for the treatment of traumatic brain injuries, offering promise for its ability to enhance the brain’s natural defense mechanisms and reduce the neurological damage associated with such injuries. Nevertheless, further research and clinical studies are essential to validate its efficacy and safety in humans as a neuroprotective agent.
LTL as anti-inflammatory
The article titled “Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies” by Nur Aziz et al., published in the Journal of Ethnopharmacology in 2018, provides a comprehensive analysis of the anti-inflammatory properties of luteolin. This review encompasses a wide range of research studies, including in vitro, in vivo, and in silico experiments, highlighting the diverse and substantial evidence supporting luteolin’s anti-inflammatory effects. Luteolin, a naturally occurring flavonoid found in various plants, and its glucoside derivative, Luteolin 7-Glucoside, are shown to possess potent anti-inflammatory properties by inhibiting pro-inflammatory cytokines, enzymes, and signaling pathways. Luteolin modulates immune responses and reduces the production of inflammatory mediators, making it a promising candidate for the treatment of inflammatory diseases. The collective findings from this review emphasize the potential of luteolin as a natural anti-inflammatory agent, paving the way for further investigations and potential therapeutic applications in conditions characterized by chronic inflammation.
LTL as anti-tumor
The article titled “Research Progress with Luteolin as an Anti-Tumor Agent” by Cai Z. et al., published in Natural Product Communications in 2022, provides insights into the anti-tumor properties of Luteolin. The study reviews and discusses the progress in utilizing Luteolin as an anti-tumor agent, shedding light on its potential in cancer prevention and therapy. Luteolin is shown to exhibit anti-tumor effects through various mechanisms, including the inhibition of cancer cell proliferation, induction of apoptosis (programmed cell death), and modulation of signaling pathways involved in tumor growth and metastasis. In the article “Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats” by Ramar Perumal Samy et al., researchers investigated luteolin’s ability to inhibit tumor promotion in a rat model of mammary tumors induced by a carcinogenic compound. The research findings suggest that luteolin possesses significant anti-tumor promoting potential, as it effectively reduces the development of mammary tumors in the experimental rats. This effect is attributed to luteolin’s ability to modulate various cellular processes involved in carcinogenesis, including inflammation and oxidative stress. Additionally, Luteolin’s antioxidant and anti-inflammatory properties contribute to its potential in preventing and combating cancer. The article underscores the importance of continued research into Luteolin’s therapeutic applications in cancer treatment, highlighting its promise as a natural compound that may complement existing cancer therapies or serve as a basis for the development of novel anti-tumor agents.
Background info
Quercetin (QUC) is a flavonoid compound that is found in various plants, including cannabis. It is a polyphenolic substance known for its antioxidant, anti-inflammatory, and potential health-promoting properties. In cannabis, quercetin is one of several flavonoids present, contributing to the plant’s complex chemical composition. Quercetin has garnered attention for its interaction with the endocannabinoid system, which plays a crucial role in regulating various physiological processes in the human body. While research on quercetin’s specific effects within cannabis is limited, its antioxidant and anti-inflammatory properties suggest that it may have potential therapeutic applications, particularly in the context of medical cannabis where the interplay of various compounds is of interest. Further studies are needed to elucidate the precise role and therapeutic potential of quercetin in cannabis and its impact on the overall physiological effects of the plant.
QUC as antioxidant
The article titled “A Review Of Quercetin: Antioxidant and Anticancer Properties” by Bahgel et al., discusses the antioxidant properties of Quercetin. Quercetin is known for its robust antioxidant activity, which plays a crucial role in protecting cells and tissues from oxidative stress and damage caused by free radicals. As a potent scavenger of free radicals, Quercetin helps to neutralize these harmful molecules, thereby reducing the risk of oxidative damage to DNA, proteins, and lipids. This antioxidant capability is particularly relevant in the context of cancer prevention and therapy since oxidative stress is implicated in the initiation and progression of various cancers. Quercetin’s ability to counteract oxidative stress contributes to its potential anticancer properties, making it a valuable subject of research for its role in promoting overall health and well-being. While this review underscores Quercetin’s antioxidant attributes, further research is required to explore its specific mechanisms of action and its full potential in preventing and treating cancer and other oxidative stress-related conditions.
QUC as Anti-inflammatory
The article titled “Anti-inflammatory, anti-proliferative, and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models” by Robert Kleemann et al., published in Atherosclerosis in 2011, presents compelling evidence regarding the anti-inflammatory properties of quercetin. This study investigates quercetin’s effects in both in vitro and in vivo models, demonstrating its ability to reduce inflammation. Quercetin is shown to have anti-inflammatory effects by suppressing inflammatory mediators and pathways, which play a crucial role in the development of atherosclerosis and other chronic inflammatory conditions. Additionally, the study suggests that quercetin has anti-proliferative properties, potentially hindering the growth of cells associated with atherosclerotic plaques. These findings underscore quercetin’s potential as a natural anti-inflammatory agent, with implications for the management and prevention of atherosclerosis and other inflammatory diseases. While further research and clinical studies are necessary to explore its full therapeutic potential, this study provides valuable insights into the anti-inflammatory properties of quercetin.
QUC as anti-allergy
The article titled “Quercetin with the potential effect on allergic diseases” by Jafarinia et al., published in the journal Allergy Asthma Clin Immunol in 2020, provides valuable insights into the anti-allergy properties of quercetin. Quercetin, a natural flavonoid found in various fruits, vegetables, and herbs, is known for its potential to modulate the immune system and reduce inflammation. The study highlights quercetin’s capacity to mitigate allergic diseases, suggesting that it may be effective in alleviating symptoms associated with allergies such as sneezing, itching, and congestion. Quercetin is thought to exert its anti-allergy effects by inhibiting the release of histamine and other inflammatory mediators, thereby reducing allergic reactions. Additionally, it may help regulate immune responses and suppress the production of pro-inflammatory cytokines. While this research underscores quercetin’s potential as a natural remedy for allergic conditions, further clinical studies and trials are necessary to ascertain its efficacy and safety for widespread use in managing allergies. Nonetheless, these findings offer promising prospects for quercetin’s role in the management of allergic diseases.
Background info
Myricetin (MYC) is a flavonoid compound that is found not only in cannabis but also in a variety of other plants, including berries, onions, and certain vegetables. It belongs to the flavonol subclass of flavonoids and is known for its potential health benefits. In cannabis, myricetin is one of several flavonoids present in the plant, contributing to the complex chemical profile of the cannabis plant. Myricetin has gained attention for its antioxidant and anti-inflammatory properties, which make it a subject of interest in medical and therapeutic research. These properties suggest that myricetin may play a role in protecting cells from oxidative damage and reducing inflammation, which are factors associated with various chronic diseases. However, the specific actions and potential therapeutic applications of myricetin in the context of cannabis are still an area of ongoing investigation, and more research is needed to fully understand its effects and potential benefits.
MYC as antioxidant
The article titled “Antioxidant activity of quercetin and myricetin in liposomes” by Michael H. Gordon and Andrea Roedig-Penman, published in the Chemistry and Physics of Lipids in 1998, provides valuable insights into the antioxidant properties of myricetin. The study investigates the antioxidant activity of myricetin in liposomes, which are lipid-based structures that mimic cell membranes. The research findings demonstrate that myricetin exhibits significant antioxidant activity in this model system, effectively protecting liposomes from oxidative damage. This suggests that myricetin has the ability to scavenge free radicals and reduce lipid peroxidation, which are processes associated with oxidative stress and cellular damage. Myricetin’s antioxidant properties are attributed to its chemical structure, which includes multiple hydroxyl groups that can neutralize reactive oxygen species. Additionally, according to “Myricetin suppresses oxidative stress-induced cell damage via both direct and indirect antioxidant action” by Zhi Hong Wang et al., Myricetin indirectly enhances the cellular antioxidant defense systems, such as the activity of superoxide dismutase (SOD) and catalase (CAT). These findings underscore myricetin’s potential as a potent natural antioxidant, which may have applications in protecting cells and tissues from oxidative stress-related diseases and conditions, including cardiovascular disease, neurodegenerative disorders, and cancer. However, further research is needed to explore its effects in vivo and its practical applications in human health.
MYC as anti-inflammatory
The article titled “Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models” by Wei Hou et al., published in Future Medicinal Chemistry in 2018, provides valuable insights into the anti-inflammatory properties of myricetin. The study demonstrates that myricetin effectively attenuates inflammation induced by lipopolysaccharide (LPS) in both macrophage cell models and mouse models. Myricetin’s ability to reduce the production of pro-inflammatory molecules and cytokines suggests its potential as an anti-inflammatory agent. The article “Myricetin: A comprehensive review on its biological potentials” by Imran et al., explains myricetin’s ability to modulate various inflammatory pathways and signaling molecules, including cytokines and enzymes like cyclooxygenase (COX) and lipoxygenase (LOX), which are central players in the inflammatory response. The findings highlight myricetin’s capacity to modulate the immune response and suppress the inflammatory process, making it a promising candidate for the development of anti-inflammatory therapies. However, while this research underscores the potential benefits of myricetin in managing inflammation, further studies and clinical trials would be necessary to confirm its efficacy and safety for use in human inflammatory conditions.
MYC as anti-tumor
The article titled “Anti-tumor effects and associated molecular mechanisms of myricetin” by Min Jiang et al., published in Biomedicine & Pharmacotherapy in 2019, provides a comprehensive analysis of the anti-tumor properties of myricetin. The study delves into the mechanisms underlying myricetin’s potential as an anticancer agent. Myricetin, a flavonoid found in various fruits and vegetables, is shown to exert anti-tumor effects through several molecular pathways. It is reported to inhibit cancer cell proliferation, induce apoptosis (programmed cell death) in cancer cells, and interfere with tumor angiogenesis and metastasis. These actions are attributed to myricetin’s ability to modulate various cellular signaling pathways, including those related to inflammation and oxidative stress. Additionally, myricetin is noted for its potential to enhance the effectiveness of conventional cancer therapies and mitigate their side effects. While the study provides valuable insights, further research, including clinical trials, is needed to validate myricetin’s efficacy and safety as a potential therapeutic agent in cancer treatment. Nonetheless, these findings highlight the promising potential of myricetin in the fight against cancer and its multifaceted role in suppressing tumor growth.
Background info
Can Flavin B (CFB) is a flavonoid compound found in cannabis, contributing to the complex chemical profile of the plant. Flavonoids are a diverse group of naturally occurring compounds known for their potential health benefits. In the context of cannabis, CFB is one of several flavonoids present in the plant, alongside cannabinoids like THC and CBD. While cannabinoids have been the primary focus of cannabis research, flavonoids like CFB have gained attention for their potential therapeutic properties. CFB is recognized for its antioxidant and anti-inflammatory properties, which make it a subject of interest in medical and therapeutic research. These properties suggest that CFB may play a role in protecting cells and tissues from oxidative stress and inflammation, both of which are associated with various chronic diseases. However, the specific actions and potential medical applications of CFB in the context of cannabis are still areas of ongoing investigation, and more research is needed to understand its effects fully and explore its potential benefits.
CFB as anti-inflammatory
The article titled “Cannflavins – From plant to patient: A scoping review” by Simon Erridge et al., published in Fitoterapia in 2020, explores the potential anti-inflammatory properties of Cannflavin B (CFB). Cannflavins are a group of flavonoids found in the cannabis plant, and CFB is one of its constituents. The research discussed in the article suggests that CFB exhibits anti-inflammatory properties that may be beneficial for various health conditions associated with inflammation. These properties stem from CFB’s ability to modulate inflammatory signaling pathways and reduce the production of pro-inflammatory molecules. While the study highlights the anti-inflammatory potential of CFB, further research is necessary to fully understand its mechanisms of action and its efficacy in clinical settings. Nonetheless, these findings underscore the potential of CFB as a natural compound with anti-inflammatory attributes, opening the door to explore its therapeutic applications in addressing inflammatory disorders.
Background info
Vitexin (VIX) is a flavonoid compound found in various plants, including cannabis. Flavonoids are a diverse group of naturally occurring compounds known for their potential health benefits. In cannabis, vitexin is one of several flavonoids present, contributing to the complex chemical composition of the plant. While cannabis is primarily associated with cannabinoids such as THC and CBD, flavonoids like vitexin have gained attention for their potential therapeutic properties. Vitexin is recognized for its antioxidant and anti-inflammatory properties, which make it a subject of interest in medical and therapeutic research. These properties suggest that vitexin may play a role in protecting cells and tissues from oxidative stress and inflammation, both of which are implicated in various chronic diseases. However, the specific actions and potential medical applications of vitexin in the context of cannabis are still areas of ongoing investigation, and more research is needed to understand its effects fully and explore its potential benefits.
VIX as anti-inflammatory
The article titled “Vitexin reduces neutrophil migration to the inflammatory focus by down-regulating pro-inflammatory mediators via inhibition of the p38, ERK1/2, and JNK pathway” by Suellen Iara Guirra Rosa et al., published in Phytomedicine in 2016, provides valuable insights into the anti-inflammatory properties of vitexin. The study explores how vitexin can effectively reduce neutrophil migration to inflammatory sites by modulating pro-inflammatory mediators and inhibiting specific signaling pathways, including p38, ERK1/2, and JNK. Neutrophil migration is a key component of the inflammatory response, and excessive or uncontrolled migration can contribute to chronic inflammation and tissue damage. Vitexin’s ability to mitigate this process by regulating pro-inflammatory pathways highlights its potential as an anti-inflammatory agent. These findings suggest that vitexin may have therapeutic applications in conditions characterized by excessive inflammation, although further research is needed to assess its safety and efficacy in clinical settings. Additionally, The study “Pre-treatment but not co-treatment with vitexin alleviates hyperthermia-induced oxidative stress and inflammation in buffalo mammary epithelial cells” by S. Senthamilan et al., suggests that pre-treatment with vitexin can alleviate oxidative stress and inflammation in buffalo mammary epithelial cells exposed to hyperthermia. Indicating that vitexin may have a protective effect against inflammatory responses induced by external stressors. These studies underscore vitexin’s promising role in modulating the inflammatory response, potentially offering a natural and alternative approach to inflammation management.
VIX as an analgesic
The article titled “Vitexin inhibits pain and itch behavior via modulating TRPV4 activity in mice” by Zhiqiang Qin et al., published in Biomedicine & Pharmacotherapy in 2023, sheds light on the analgesic properties of vitexin. The study explores how vitexin effectively inhibits pain and itch behavior in mice, suggesting its potential as an analgesic agent. The research findings indicate that vitexin achieves this by modulating the activity of the TRPV4 ion channel, which is known to play a role in pain and itch perception. By targeting TRPV4, vitexin may reduce the transmission of pain and itch signals, providing relief from these sensations. While the study focuses on animal models, these findings highlight the potential of vitexin as a natural compound with analgesic properties, offering a promising avenue for further research in the development of pain-relief treatments. However, additional research, including clinical trials, is needed to confirm its safety and efficacy in humans and explore its practical applications in pain management.
VIX as antinociceptive
The article titled “Antinociceptive effects of vitexin in a mouse model of postoperative pain” by Zhu et al., published in Scientific Reports in 2016, provides valuable insights into the antinociceptive properties of vitexin. The study investigates vitexin’s ability to alleviate postoperative pain in a mouse model. The research findings suggest that vitexin exhibits significant antinociceptive effects, indicating its potential as a pain-relieving compound. This property is particularly significant in the context of postoperative pain management, as it suggests that vitexin could offer a natural and potentially safer alternative to traditional analgesics. The study also suggests that vitexin’s antinociceptive effects may be mediated through the modulation of various pain pathways. While this research offers promising evidence, further studies and clinical trials are needed to validate the efficacy and safety of vitexin in human pain management and to explore its potential as a therapeutic agent for various types of pain disorders. Nonetheless, these findings highlight vitexin’s potential as a natural analgesic compound.
VIX anti-depressant
The article titled “Anti-depressant-like effect of vitexin in BALB/c mice and evidence for the involvement of monoaminergic mechanisms” by Özgür Devrim Can et al., published in the European Journal of Pharmacology in 2013, provides valuable insights into the potential antidepressant properties of Vitexin. This study explores Vitexin’s impact on behavior in mice, suggesting that it exhibits an antidepressant-like effect. The research findings point to the involvement of monoaminergic mechanisms, which are related to the regulation of neurotransmitters like serotonin, dopamine, and norepinephrine, all of which play crucial roles in mood regulation. Vitexin is suggested to influence these neurotransmitter systems, which are implicated in depression. While the study provides promising evidence for Vitexin’s potential as a natural antidepressant, further research and clinical trials would be necessary to confirm its efficacy and safety in humans. Nonetheless, these findings highlight the potential of Vitexin as a novel compound in the quest for alternative treatments for depressive disorders.
Background info
Isovitexin (ISX) is a flavonoid compound that can be found in various plants, including cannabis. Flavonoids are a diverse group of naturally occurring compounds known for their potential health benefits. In the context of cannabis, isovitexin is one of several flavonoids present in the plant, contributing to its chemical complexity. While cannabis is primarily associated with cannabinoids like THC and CBD, flavonoids like isovitexin have gained attention for their potential therapeutic properties. Isovitexin is recognized for its antioxidant and anti-inflammatory properties, which suggest its potential role in protecting cells and tissues from oxidative stress and inflammation, both of which are associated with various chronic diseases. However, the specific actions and potential medical applications of isovitexin in the context of cannabis are still areas of ongoing research, and more studies are needed to fully understand its effects and explore its potential benefits.
ISX as antioxidant
The article titled “Comprehensive Assessment of Antioxidant Activities of Apigenin Isomers: Vitexin and Isovitexin” by Khole et al., published in Free Radicals and Antioxidants in 2016, provides insights into the antioxidant properties of isovitexin (ISX), a flavonoid found in various plants, including cannabis. The study examines the antioxidant activities of isovitexin and its isomer, vitexin, and highlights their potential to combat oxidative stress. The research findings suggest that isovitexin exhibits significant antioxidant properties, which can help neutralize harmful free radicals and reduce oxidative damage to cells and tissues. This antioxidant activity is crucial in protecting against various chronic diseases and age-related conditions. Although the article primarily focuses on the antioxidant properties of isovitexin and its isomer, it underscores the potential health benefits of this flavonoid, suggesting its role in promoting overall well-being and potentially contributing to the prevention of oxidative stress-related disorders.
ISX as anti-inflammatory
The article titled “Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways” by Lv et al., published in the International Journal of Biological Sciences in 2016, provides evidence supporting the anti-inflammatory properties of isovitexin (ISX). The study investigates ISX’s effects on lipopolysaccharide-induced acute lung injury and elucidates its mechanisms of action. ISX is found to exert anti-inflammatory activities by inhibiting pro-inflammatory pathways, specifically the MAPK and NF-κB pathways, which are associated with the production of inflammatory mediators. Additionally, ISX activates the HO-1/Nrf2 pathways, which are linked to antioxidant defense and anti-inflammatory responses. This dual action of ISX in reducing inflammation and enhancing antioxidant defenses highlights its potential as a natural compound with anti-inflammatory properties. While the research focuses on acute lung injury, these findings suggest that ISX may have broader applications in addressing inflammatory conditions and oxidative stress-related diseases, emphasizing its significance in the realm of natural anti-inflammatory therapies. One example of this is found in the article titled “Isovitexin-mediated regulation of microglial polarization in lipopolysaccharide-induced neuroinflammation via activation of the CAMKKβ/AMPK-PGC-1α signaling axis” by Liu et al., published in Frontiers in 2019. This study highlights the potential anti-inflammatory properties of isovitexin (ISX). It focuses on isovitexin’s role in modulating microglial polarization in the context of neuroinflammation. Microglial cells are key players in the brain’s immune response, and their polarization state can have profound effects on inflammation. The research findings suggest that isovitexin can influence microglial polarization in response to lipopolysaccharide-induced neuroinflammation. This effect is attributed to isovitexin’s ability to activate the CAMKKβ/AMPK-PGC-1α signaling axis, a pathway known to regulate cellular energy metabolism and inflammation. By modulating microglial polarization and reducing neuroinflammation, isovitexin demonstrates its potential as a natural anti-inflammatory agent with implications for neuroprotection and potentially broader applications in managing inflammatory conditions. However, further research, including clinical studies, is needed to validate these findings and explore the full extent of isovitexin’s anti-inflammatory properties and therapeutic potential.
ISX as an anxiolytic
The article titled “Flavones-bound in benzodiazepine site on GABAA receptor: Concomitant anxiolytic-like and cognitive-enhancing effects produced by Isovitexin and 6-C-glycoside-Diosmetin” by Daniela Rodrigues de Oliveira et al., published in the European Journal of Pharmacology in 2018, provides valuable insights into the anxiolytic (anxiety-reducing) properties of isovitexin (ISX). The study suggests that ISX, a flavonoid found in various plants, including cannabis, exhibits anxiolytic-like effects by binding to the benzodiazepine site on the GABAA receptor. This interaction with the GABAergic system is significant, as it is a key player in regulating anxiety and stress responses in the brain. The research findings indicate that ISX may have the potential to reduce anxiety-like behaviors in animal models, suggesting its anxiolytic properties. Furthermore, the study suggests that ISX might also enhance cognitive function. While this research is promising, further studies are needed, particularly clinical trials in humans, to fully assess the efficacy and safety of ISX as an anxiolytic agent. Nonetheless, these findings offer exciting prospects for the use of ISX in addressing anxiety-related conditions.
Background info
Can Flavin A (CFA) is a flavonoid compound found in cannabis, a plant known for its diverse chemical composition, including cannabinoids, terpenes, and flavonoids. Flavonoids are natural polyphenolic compounds that contribute to the color, flavor, and potential health benefits of plants. In cannabis, flavonoids like CFA are part of the complex chemical profile of the plant, often working synergistically with cannabinoids and terpenes to produce various effects. While cannabis is most commonly associated with cannabinoids like THC and CBD, flavonoids like CFA have gained attention for their potential therapeutic properties, including antioxidant and anti-inflammatory effects. However, the specific actions and potential medical applications of CFA in the context of cannabis are still areas of ongoing research, and more studies are needed to fully understand its effects and explore its potential benefits.
CFA as anti-inflammatory
The article titled “Cannflavins – From plant to patient: A scoping review” by Simon Erridge et al., published in Fitoterapia in 2020, offers insights into the potential anti-inflammatory properties of Cannflavin A (CFA). Cannflavins are a group of flavonoids found primarily in cannabis, and CFA is one of the notable compounds within this group. The study suggests that CFA exhibits anti-inflammatory properties, which may be attributed to its chemical structure and its interaction with various molecular pathways involved in inflammation. Flavonoids, including CFA, are known for their ability to modulate inflammatory responses by inhibiting pro-inflammatory enzymes and cytokines. These findings suggest that CFA has the potential to be developed as a natural anti-inflammatory agent, which could have implications for the treatment of inflammatory conditions and diseases. However, further research and clinical studies are needed to fully understand CFA’s mechanisms of action, safety profile, and its therapeutic potential in humans.
Background info
Orientin (ORT) is a flavonoid compound found in various plants, including cannabis. Flavonoids are a class of naturally occurring polyphenolic compounds known for their potential health benefits. In the context of cannabis, orientin is one of several flavonoids present in the plant, contributing to its chemical composition. While cannabis is primarily associated with cannabinoids like THC and CBD, flavonoids like orientin have gained attention for their potential therapeutic properties. Orientin is recognized for its antioxidant and anti-inflammatory properties, suggesting its potential role in protecting cells and tissues from oxidative stress and inflammation, both of which are implicated in various chronic diseases. However, the specific actions and potential medical applications of orientin in the context of cannabis are still areas of ongoing research, and more studies are needed to fully understand its effects and explore its potential benefits.
ORT as anti-inflammatory
The study by Xiao et al. titled “Orientin ameliorates LPS-induced inflammatory responses through the inhibition of the NF-κB pathway and NLRP3 inflammasome,” published in Evidence-Based Complementary and Alternative Medicine in 2017, highlights the anti-inflammatory properties of orientin. The research findings suggest that orientin, a flavonoid compound found in various plants, possesses significant anti-inflammatory capabilities. It achieves this by inhibiting the activation of the NF-κB pathway, a key regulator of pro-inflammatory genes, and the NLRP3 inflammasome, a multiprotein complex involved in the production of pro-inflammatory cytokines. By modulating these inflammatory pathways, orientin effectively reduces the production of inflammatory molecules and attenuates the inflammatory response triggered by lipopolysaccharide (LPS), a bacterial endotoxin. The research in “Orientin relieves lipopolysaccharide-induced acute lung injury in mice: The involvement of its anti-inflammatory and anti-oxidant properties” by Qingfei Xiao et al., published in the International Immunopharmacology in 2021, also focuses on the potential therapeutic role of orientin in mitigating acute lung injury induced by lipopolysaccharide (LPS) in mice. The study demonstrates that orientin effectively reduces inflammation and oxidative stress in the lung tissues of the mice. Orientin achieves this by suppressing the release of pro-inflammatory cytokines and modulating antioxidant enzymes. These findings underline orientin’s capacity to alleviate inflammatory responses and oxidative damage, highlighting its potential as a natural anti-inflammatory agent. These findings underscore the potential of orientin as a natural anti-inflammatory agent and support its exploration as a therapeutic option for various inflammatory conditions. However, further research, including clinical studies, is necessary to evaluate its efficacy and safety in human applications.
ORT as antioxidant
The article titled “Antioxidant potential of orientin: A combined experimental and DFT approach” by R. Praveena et al., published in the Journal of Molecular Structure in 2014, provides insights into the antioxidant properties of orientin. Orientin is a flavonoid known for its potential health benefits, and this study explores its antioxidant potential using both experimental and computational approaches. The research findings suggest that orientin exhibits significant antioxidant activity, capable of scavenging free radicals and reducing oxidative stress. This property is attributed to its chemical structure, which includes multiple hydroxyl groups that can neutralize reactive oxygen species. These findings underscore the potential of orientin as a potent natural antioxidant, which may have applications in protecting cells and tissues from oxidative damage, thus potentially contributing to its role in maintaining overall health and preventing oxidative stress-related diseases. However, further research is needed to fully understand its mechanisms of action and practical applications in human health.
ORT for blood glucose regulation
The article titled “In silico and in vitro studies of lupeol and iso-orientin as potential antidiabetic agents in a rat model” by Arif Malik et al., published in Drug Design, Development and Therapy in 2019, investigates the potential role of orientin, particularly iso-orientin, in blood glucose regulation. The study employs in silico and in vitro methods to explore the antidiabetic properties of iso-orientin in a rat model. Iso-orientin is suggested to act as a potential antidiabetic agent by influencing blood glucose levels. It is thought to exert its effects by enhancing insulin sensitivity, which is crucial for glucose uptake by cells, and by promoting glucose metabolism. These findings suggest that iso-orientin may have a role in the management of diabetes by contributing to the regulation of blood glucose levels. However, further research, including clinical studies, is essential to validate its efficacy and safety as a potential treatment for diabetes in humans. Nonetheless, these results highlight iso-orientin’s potential as a natural compound with blood glucose-regulating properties.
ORT as neuroprotective
The article titled “Neuroprotective effects of orientin on hydrogen peroxide-induced apoptosis in SH-SY5Y cells” by Law et al., published in Molecular Medicine Reports in 2014, highlights the neuroprotective properties of orientin. The study investigates how orientin, a flavonoid compound found in various plants, including cannabis, can protect neuronal cells from apoptosis (cellular programmed death) induced by hydrogen peroxide, a potent oxidative stressor. The research findings indicate that orientin exhibits neuroprotective effects by reducing oxidative stress and preventing the activation of apoptotic pathways in SH-SY5Y cells, a commonly used neuronal cell line. These results suggest that orientin may have potential applications in protecting neurons from damage and degeneration, making it a subject of interest in neuroprotection research. Additionally, the study “Neuroprotection of Cyperus esculentus L. orientin against cerebral ischemia/reperfusion induced brain injury” by Jing et al., published in Neural Regeneration Research in 2020, explores how orientin can provide protection to the brain during cerebral ischemia/reperfusion injury, a condition where blood flow to the brain is temporarily disrupted and then restored. The research findings suggest that orientin exerts neuroprotection by reducing oxidative stress, suppressing inflammation, and mitigating neuronal damage, ultimately preserving brain function in the face of ischemic insult. However, further studies, including in vivo experiments and clinical trials, would be necessary to validate its neuroprotective efficacy and explore its potential for therapeutic use in neurodegenerative conditions. Nonetheless, these findings emphasize the promising neuroprotective potential of orientin.
Background info
Δ9-Tetrahydrocannabivarin (THCV) is a naturally occurring cannabinoid compound found in the Cannabis sativa plant. It shares a similar molecular structure with the more well-known cannabinoid, Δ9-tetrahydrocannabinol (THC), which is responsible for the psychoactive effects of cannabis. However, THCV has distinct effects and properties. It has garnered interest due to its potential therapeutic applications in various medical conditions. THCV’s effects on the endocannabinoid system, which plays a crucial role in regulating various physiological processes, are of particular interest. Additionally, THCV’s potential to affect insulin sensitivity, glucose regulation, and lipid metabolism has sparked attention in the context of metabolic disorders like obesity and diabetes. While THCV’s mechanisms and effects are still being explored, its distinct properties and potential therapeutic benefits make it an intriguing subject of scientific investigation.
Background info
Δ9-Tetrahydrocannabivarin (THCV) is a naturally occurring cannabinoid compound found in the Cannabis sativa plant. It shares a similar molecular structure with the more well-known cannabinoid, Δ9-tetrahydrocannabinol (THC), which is responsible for the psychoactive effects of cannabis. However, THCV has distinct effects and properties. It has garnered interest due to its potential therapeutic applications in various medical conditions. THCV’s effects on the endocannabinoid system, which plays a crucial role in regulating various physiological processes, are of particular interest. Additionally, THCV’s potential to affect insulin sensitivity, glucose regulation, and lipid metabolism has sparked attention in the context of metabolic disorders like obesity and diabetes. While THCV’s mechanisms and effects are still being explored, its distinct properties and potential therapeutic benefits make it an intriguing subject of scientific investigation.
By entering the site you have read and agree to Acannability’s use of cookies, Privacy Policy, and Disclaimer*